Hangzhou Ming CIBA Vision Eye Hospital

What Hangzhou Ming CIBA Vision Eye Hospital does

Hangzhou Ming CIBA Vision Eye Hospital is a privately held, single-site specialized ophthalmology day surgery center founded in 2001 in Hangzhou, China, operating from a facility at 384 Fengqi Road. The hospital provides a full-lifecycle eye care portfolio spanning refractive surgery (personalized femtosecond LASIK, all-femtosecond SMILE, ICL/EVO ICL lens implantation, Full-light Sculpture 3D corneal refractive surgery), presbyopia and cataract treatment (femtosecond trifocal lens replacement), pediatric myopia control (orthokeratology/OK lenses, peripheral defocus lenses, red light therapy), and dry eye management (IPL). It serves direct-to-consumer adult and pediatric patients across multiple use cases including elective vision correction, career-mandated vision standards, and pediatric myopia progression control.

The hospital's competitive position rests on a proprietary suite of ZZ-series calculation algorithms (ZZ-IOL, ZZ-TIOL, ZZ-ICL, ZZ-TICL, ZZ-OK, ZZ Full-light Sculpture Optimization) that have been granted national invention patents in China and adopted by ophthalmologists in 40+ countries. It holds designated training/clinical partnership status with all major global ophthalmic device OEMs — Alcon, VISX, Sirius (CSO), Carl Zeiss, and STAAR Surgical — and is recognized as a Zhejiang Provincial-level eye refraction clinical specialty department and a National High-Tech Enterprise. Clinical leadership is concentrated in founder Dr. Zheng Li (200,000+ refractive surgeries since 1995, national standard-setting committee member) and Research President Dr. Zhang Jun (multiple national patents, SCI publications, 2025 Eyetube award recipient).

The business model is direct-pay patient services with per-procedure pricing (FullFemto SMILE promotional at 16,800 RMB, Full-light Sculpture at 30% discount, ICL with 2,000 RMB reduction), supported by recurring revenue from orthokeratology lens replacements and ongoing pediatric follow-up. Patient acquisition relies on a digital-first GTM motion (mskyk.com, WeChat official account EYE85318888, phone hotlines, online booking), celebrity and professional athlete testimonial marketing, national media coverage (CCTV, Xinhua, People's Daily Health), and academic-conference-driven referral networks. Distribution is exclusively direct at the single physical facility; no third-party reseller or franchise channels are utilized.

Name

Hangzhou Ming CIBA Vision Eye Hospital

Legal name

杭州明视康眼科医院有限公司

Website

https://mskyk.com

Company type

Private

Founded year

2001

Operating status

Operating

Short description

Hangzhou Ming CIBA Vision Eye Hospital is a single-site specialized ophthalmology day surgery center in Hangzhou, China, founded 2001, offering refractive surgery, pediatric myopia control, presbyopia, and cataract treatments backed by proprietary patented ZZ formula algorithms and partnerships with Alcon, ZEISS, and STAAR Surgical.

Ownership category

akta.pro rank

Product category

Ophthalmology and Refractive Surgery Services

NAICS

Offices of Optometrists (62132), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Ophthalmic Goods (3851)

akta.pro primary industry

Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC)

akta.pro secondary industries

Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF), Contact Lens Specialty & Myopia Control (HLAKAKAK), Refractive Surgery Systems (Excimer/Femtosecond Lasers, Phakic IOL Systems, Wavefront/Guidance) (HLAHAJAG), Ophthalmology Surgery Centers (HLAFAIAF)

Keywords

• Refractive surgery services
• Ophthalmology hospital services
• Myopia control treatments
• Cataract surgery services
• Orthokeratology lens fitting

Headquarters

HQ city

Hangzhou

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Refractive Surgery Services: Revenue from corrective eye surgeries including personalized FS-LASIK, all-femtosecond (全飞秒), ICL lens implantation, and full-light sculpture (全光塑). These are high-value, one-time procedures for myopia, hyperopia, astigmatism, and presbyopia correction.
2. Corneal Orthokeratology (OK Lens / 角膜塑形镜): Revenue from overnight contact lens fitting for myopia control in children and adolescents. Patients pay for lens fitting, custom lenses, and ongoing follow-up visits and solutions. Annual replacement lenses and护理 products generate recurring revenue.
3. Trifocal IOL Lens Replacement (飞秒三焦点晶体置换术): Premium cataract and presbyopia surgery using trifocal intraocular lenses. Revenue from the surgical procedure including lens implantation, targeting middle-aged and elderly patients seeking complete vision restoration.
4. Myopia Control Interventions (周边离焦镜, 哺光仪): Revenue from peripheral defocus lenses, low-concentration atropine eye drops, and red light therapy devices (哺光仪) for myopia progression control in children and adolescents.
5. Medical Examinations and Vision Health Services: Revenue from comprehensive eye examinations, vision health assessments, vision file establishment (especially for children), and related diagnostic services.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Hangzhou Ming CIBA Vision Eye Hospital operates as a specialized ophthalmic day surgery center providing refractive surgery (Personalized Femtosecond LASIK, All-Femtosecond SMILE, ICL Implantation, All-Light Sculpture), presbyopia/cataract treatment (Femtosecond Trifocal Lens Replacement), and pediatric myopia control (Orthokeratology/OK lenses, peripheral defocus lenses, red light therapy). The hospital applies its proprietary ZZ formula calculation algorithms for personalized surgical planning and precision treatment.

Product overview

杭州明视康眼科医院 operates as a specialized ophthalmic day surgery center offering a comprehensive, full-lifecycle eye care portfolio spanning refractive surgery, myopia control, presbyopia correction, and cataract treatment. The core surgical portfolio includes Personalized Femtosecond LASIK, All-Femtosecond LASIK (SMILE), ICL Lens Implantation, All-Light Sculpture (全光塑) as the newest generation platform, Femtosecond Presbyopia Laser Correction, and Femtosecond Trifocal Lens Replacement Surgery. These are supported by proprietary ZZ-series calculation algorithms (ZZ-OK, ZZ-ICL, ZZ-IOL, ZZ-TIOL) for personalized treatment planning. The myopia control ecosystem includes Orthokeratology Lenses (OK镜), Peripheral Defocus Spectacle Lenses, Red Light Therapy Devices (哺光仪), and IPL Dry Eye Treatment. The hospital serves both adult patients (refractive surgery, presbyopia, cataracts) and pediatric patients (juvenile myopia prevention and control), functioning as an integrated eye hospital with specialized centers for refractive surgery, pediatric myopia, and comprehensive ophthalmology.

Differentiator

Problem solved

Functional benefit

Brands

• ZZ公式: Proprietary calculation formula developed by the hospital for personalized refractive surgery and lens selection, applied across multiple procedure types including IOL, TICL, OK lens, and ICL.

Products and services

• Personalized Femtosecond LASIK (个性化飞秒近视手术) A corneal refractive surgery combining femtosecond and excimer laser technologies, available in multiple customized variants to achieve superior postoperative visual quality. Designed for adult patients seeking to eliminate dependence on glasses or contact lenses.
• All-Femtosecond LASIK / SMILE (全飞秒近视手术) A bladeless, small-incision corneal refractive surgery using only femtosecond laser technology to create and extract a corneal lenticule. Suitable for low-to-moderate myopia patients with regular astigmatism.
• ICL / EVO ICL Lens Implantation (ICL人工晶体植入术) An implantable collamer lens surgery that corrects myopia and astigmatism without corneal tissue removal. Reversible with broad correction range (up to 1800 degrees), excellent night vision, and UV protection. The hospital uses proprietary ZZ-ICL and ZZ-TICL formulas for precise lens sizing and vault prediction.
• Femtosecond Presbyopia Laser Correction (飞秒老花矫正术) A corneal laser surgery using monovision design and Q-value adjustment to simultaneously correct myopia and presbyopia for patients aged 40-50, allowing freedom from reading glasses.
• Femtosecond Trifocal Lens Replacement Surgery (飞秒三焦点晶体置换术) A surgical procedure that removes the aged natural lens and implants a trifocal intraocular lens using femtosecond laser assistance. Solves presbyopia, cataracts, myopia, hyperopia, and astigmatism in a single procedure to achieve clear near, intermediate, and distance vision. Targets middle-aged and elderly patients seeking complete vision restoration.
• Orthokeratology Lenses / OK Lens (角膜塑形镜) Rigid contact lenses worn overnight to temporarily reshape the cornea, providing clear daytime vision without glasses or contact lenses while controlling myopia progression in children and adolescents. The hospital uses its proprietary ZZ-OK formula for precision fitting.
• IPL Intense Pulsed Light Therapy (IPL强脉冲光技术) Intense pulsed light technology used for dry eye treatment, targeting meibomian gland dysfunction and ocular surface inflammation. Offered as a standalone therapeutic service for patients with dry eye conditions.
• All-Light Sculpture Personalized Refractive Surgery (全光塑个性化近视手术) A next-generation personalized corneal refractive surgery using 3D eye modeling, ray-tracing algorithms, and comprehensive aberration correction to achieve unprecedented precision and visual quality outcomes. The hospital's newest flagship refractive surgery technology.
• Pediatric Myopia Control Program (周边离焦镜 + 哺光仪 + 低浓度阿托品) A comprehensive pediatric myopia progression control program combining peripheral defocus spectacle lenses, red light therapy devices (哺光仪) for choroidal blood circulation improvement, and low-concentration atropine eye drops. Designed for children and adolescents with progressing myopia.

Quantifiable outcome

• Full-light sculpture (全光塑) achieves 100% patients with UCVA ≥1.0, 97.2% ≥1.2, 50% ≥1.5 at 3 months post-op, with 58% achieving ≥1 line improvement over pre-op best corrected vision
• +5 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• International Ophthalmology Exchange Partners (国内外知名医疗机构权威专家)coreStrategic or Co-development Partner · 1 November 2024Hosting international academic exchanges with global ophthalmic leaders. Alcon experts from France and Malaysia, and domestic ophthalmic experts from dozens of hospitals, have conducted immersive visits to observe refractive surgery techniques and hospital-developed ZZ formula algorithms. These exchanges have resulted in multiple expressions of collaboration intent for clinical research and equipment co-development.
• Drops of Water Public Welfare (滴水公益)minorOthers · 1 January 2022Collaborative public welfare partnership with Drops of Water Public Welfare organization for the Western Regional Student 'Dream Package' (圆梦礼包) donation program. The hospital donated dream fulfillment packages to children in western regions of China, continuing the partnership for multiple years.
• Alcon (美国爱尔康) — National Refractive Surgery Training CentercoreTechnology or IntegrationThe hospital is designated as an Alcon National Refractive Surgery Training Center, recognized as the first choice for training ophthalmic surgeons nationally. Alcon is a global ophthalmic device leader providing advanced surgical equipment. The partnership provides the hospital with cutting-edge surgical technology, international-standard equipment, and industry leadership recognition.
• VISX (美国) — National Refractive Surgery Training CentercoreTechnology or IntegrationDesignated as a VISX National Refractive Surgery Training Center. VISX provides excimer laser technology for refractive surgery. The training center status indicates mutual collaboration in surgeon education and technology dissemination.
• Sirius (意大利) — Clinical Training CentercoreTechnology or IntegrationDesignated as a Sirius Clinical Training Center. Sirius provides anterior segment diagnostic equipment (corneal topography). The partnership enables advanced diagnostic capabilities and international training standards.
• Carl Zeiss (德国蔡司) — Full-Femtosecond Surgery CentercoreTechnology or IntegrationDesignated as a ZEISS Full-Femtosecond (全飞秒) Surgery Center. Zeiss provides femtosecond laser and IOLMaster biometric equipment. The hospital is also a Zeiss IOL (蔡司IOL) Lens Replacement Center, offering comprehensive Zeiss lens options.
• STAAR Surgical (瑞士ICL晶体植入中心)coreTechnology or IntegrationDesignated as STAAR Surgical's ICL (Implantable Collamer Lens) Center. STAAR provides the EVO ICL lens for myopia correction. The hospital received EVO ICL Clinical Certification Cooperation Center status from STAAR.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Others

• Alcon: Global ophthalmic device leader providing femtosecond and excimer laser platforms to the hospital. The subject is designated an Alcon National Refractive Surgery Training Center, making Alcon both a key supplier and a co-marketing partner.
• Carl Zeiss Meditec: German manufacturer of femtosecond lasers, IOLMaster biometry, and IOLs that underpin the subject hospital's refractive and cataract surgical platforms. Designated as the hospital's Full-Femtosecond Surgery Center partner.
• STAAR Surgical: Swiss/US manufacturer of the EVO ICL lens, a core product used in the subject hospital's ICL service line. Strategic supplier relationship, evidenced by EVO ICL Clinical Certification Cooperation Center status.

Direct peers

• Brighteye (Pucheng) Eye Hospital Group: Chinese private eye hospital chain (listed on Shenzhen Stock Exchange). Competes directly in refractive surgery, ICL implantation, and cataract surgery across regional markets in China.
• Aier Eye Hospital Group: China's largest private ophthalmology hospital chain with hundreds of centers globally. Directly competes with the subject in refractive surgery, myopia control, and presbyopia/cataract, and is the primary scale benchmark for any Chinese specialty eye hospital.
• C-MER Eye Care Holdings: Hong Kong-listed ophthalmology group with growing mainland China footprint. Comparable in clinical scope (refractive surgery, cataract, ICL) and in targeting premium patients.
• Huaxia Eye Hospital Group: Major Chinese private ophthalmology chain operating across multiple provinces. Offers the same core services (refractive surgery, cataract, pediatric myopia) and competes head-to-head in mid-to-premium patient segments.

Broad incumbents

• Beijing Tongren Hospital Eye Center: Top-tier public eye center in China, recognized for high surgical volume and clinical research. Provides a public-hospital alternative for refractive and cataract patients considering the subject hospital.
• Zhongshan Ophthalmic Center (Sun Yat-sen University): One of China's leading public academic eye hospitals. Overlaps in clinical scope and serves as a major referral/training institution; competes for premium and complex cases despite its public-hospital status.

Emerging players

• Xinxiang Pucheng Eye Hospital (Aier affiliate type peers): Regional Chinese private eye hospitals expanding into refractive and cataract surgery. Comparable in service mix to the subject, but typically with thinner proprietary technology and weaker brand equity.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hangzhou Ming CIBA Vision Eye Hospital